- Report
- October 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- October 2024
- 183 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 186 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- April 2025
- 114 Pages
Global
From €5225EUR$5,450USD£4,366GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- August 2022
- 120 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- September 2022
- 117 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- April 2023
- 120 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Report
- September 2022
- 152 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Report
- April 2023
- 160 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Varenicline is a prescription medication used to treat nicotine addiction. It is a partial agonist of the nicotinic acetylcholine receptor, which helps reduce the craving for nicotine and the symptoms of withdrawal. Varenicline is also used to help people quit smoking. It works by blocking the effects of nicotine in the brain, reducing the pleasure associated with smoking and helping to reduce the urge to smoke.
Varenicline is a relatively new drug in the addiction disorders market, but it has been gaining popularity due to its effectiveness in helping people quit smoking. It is generally well-tolerated and has few side effects. It is also available in generic form, making it more affordable for those who need it.
Some of the companies in the Varenicline market include Pfizer, GlaxoSmithKline, Mylan, and Teva Pharmaceuticals. Show Less Read more
